price
JA
NASDAQ · JANX
Janux Therapeutics, Inc.
Healthcare · Biotechnology
$16.93
Down-$0.03 (-0.18%)
Updated Oct 5, 2026, 8:18 AM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 922.65M
- P/E ratio
- -9.34
- Dividend yield
- 0.00%
- 52-week range
- $12.12 – $35.34
- Volume
- 805.27K
- Avg. volume
- 1.45M
Price performance · JANX
JANX price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
JANX closed at $16.93 after 19 trading sessions, down 15.52% for the selected period.
- Last close
- $16.93
- Period change
- -15.52%
- Period low
- $16.25
- Period high
- $20.04
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $17.25 | $17.29 | $16.835 | $16.93 | 805.27K |
| Oct 1, 2026 | $17.20 | $17.35 | $16.76 | $16.96 | 837.56K |
| Sep 30, 2026 | $17.08 | $17.5634 | $16.79 | $17.28 | 772.49K |
| Sep 29, 2026 | $16.54 | $16.98 | $16.32 | $16.95 | 511.71K |
| Sep 28, 2026 | $16.57 | $16.79 | $16.16 | $16.58 | 473.05K |
| Sep 25, 2026 | $16.62 | $16.70 | $16.21 | $16.30 | 720.17K |
| Sep 24, 2026 | $16.42 | $16.79 | $15.75 | $16.68 | 1.3M |
| Sep 23, 2026 | $17.40 | $17.47 | $16.345 | $16.52 | 967.53K |
| Sep 22, 2026 | $17.17 | $17.47 | $16.97 | $17.47 | 908.29K |
| Sep 21, 2026 | $16.86 | $17.14 | $16.53 | $17.01 | 701.84K |
| Sep 18, 2026 | $16.70 | $16.86 | $16.40 | $16.59 | 2.45M |
| Sep 17, 2026 | $16.49 | $17.22 | $16.485 | $16.86 | 810.01K |
| Sep 16, 2026 | $16.43 | $16.61 | $16.04 | $16.245 | 1.16M |
| Sep 15, 2026 | $17.29 | $17.29 | $16.30 | $16.44 | 1.01M |
| Sep 14, 2026 | $17.13 | $17.5699 | $17.13 | $17.31 | 869.77K |
| Sep 11, 2026 | $17.92 | $17.94 | $17.05 | $17.10 | 791.6K |
| Sep 10, 2026 | $19.17 | $19.33 | $17.60 | $17.68 | 980.2K |
| Sep 9, 2026 | $19.94 | $20.225 | $19.27 | $19.33 | 575.98K |
| Sep 8, 2026 | $20.24 | $20.25 | $19.67 | $20.04 | 1.06M |
Latest JANX news
The latest Smart Investors Daily articles mentioning JANX.
Stock researchResearch & News · News
Company
Market Activity
Research & News
Loading stock research…

